|
The Opportunity
Advanced Proteome Therapeutics’ linkage technologies address improvement of protein therapeutics, a field of enormous and growing significance. Important factors in this field include:
- The expiration of patents on a number of protein drugs with annual sales in the billion dollar class creates major opportunities to improve patient compliance and comfort by modifying these protein drugs. Modified proteins will benefit from full patent protection.
- Discovery and development of protein therapeutics continues to be an area of robust activity. The FDA has approved over 165 biopharmaceuticals. Hundreds more are in development and many will require optimization before they can reach the marketplace.
- APT has an improved approach to developing carrier-based drug delivery. Annual sales for protein drugs in this class already exceed several billion dollars. The field is expanding rapidly. This dynamic emphasizes the favorable precedents of both regulatory and market acceptance for such an approach.
- Therapeutic proteins have the highest rate of sales growth of any type of drug over the past decade and this trend is expected to continue in light of current activity. - (IMS Health Global). The total global market for protein drugs was $47.4 billion in 2006. The market is expected to reach $55.7 billion by the end of 2011.
|
